rs143918373

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_017433.5(MYO3A):​c.1643C>A​(p.Pro548His) variant causes a missense change. The variant allele was found at a frequency of 0.000315 in 1,613,648 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0012 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00022 ( 1 hom. )

Consequence

MYO3A
NM_017433.5 missense

Scores

8
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:6B:2

Conservation

PhyloP100: 4.64
Variant links:
Genes affected
MYO3A (HGNC:7601): (myosin IIIA) The protein encoded by this gene belongs to the myosin superfamily. Myosins are actin-dependent motor proteins and are categorized into conventional myosins (class II) and unconventional myosins (classes I and III through XV) based on their variable C-terminal cargo-binding domains. Class III myosins, such as this one, have a kinase domain N-terminal to the conserved N-terminal motor domains and are expressed in photoreceptors. The protein encoded by this gene plays an important role in hearing in humans. Three different recessive, loss of function mutations in the encoded protein have been shown to cause nonsyndromic progressive hearing loss. Expression of this gene is highly restricted, with the strongest expression in retina and cochlea. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012907296).
BP6
Variant 10-26096461-C-A is Benign according to our data. Variant chr10-26096461-C-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 178465.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=6}.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00122 (185/152226) while in subpopulation AFR AF= 0.00363 (151/41556). AF 95% confidence interval is 0.00316. There are 2 homozygotes in gnomad4. There are 83 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 SD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MYO3ANM_017433.5 linkuse as main transcriptc.1643C>A p.Pro548His missense_variant 16/35 ENST00000642920.2 NP_059129.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MYO3AENST00000642920.2 linkuse as main transcriptc.1643C>A p.Pro548His missense_variant 16/35 NM_017433.5 ENSP00000495965 P1Q8NEV4-1
MYO3AENST00000543632.5 linkuse as main transcriptc.1643C>A p.Pro548His missense_variant 15/171 ENSP00000445909
MYO3AENST00000642197.1 linkuse as main transcriptn.1847C>A non_coding_transcript_exon_variant 16/27
MYO3AENST00000647478.1 linkuse as main transcriptc.1643C>A p.Pro548His missense_variant, NMD_transcript_variant 15/30 ENSP00000493932

Frequencies

GnomAD3 genomes
AF:
0.00120
AC:
183
AN:
152108
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00360
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00151
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.000419
AC:
105
AN:
250834
Hom.:
0
AF XY:
0.000265
AC XY:
36
AN XY:
135802
show subpopulations
Gnomad AFR exome
AF:
0.00346
Gnomad AMR exome
AF:
0.000868
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000141
Gnomad OTH exome
AF:
0.000656
GnomAD4 exome
AF:
0.000222
AC:
324
AN:
1461422
Hom.:
1
Cov.:
31
AF XY:
0.000212
AC XY:
154
AN XY:
727018
show subpopulations
Gnomad4 AFR exome
AF:
0.00305
Gnomad4 AMR exome
AF:
0.000850
Gnomad4 ASJ exome
AF:
0.000191
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000124
Gnomad4 OTH exome
AF:
0.000596
GnomAD4 genome
AF:
0.00122
AC:
185
AN:
152226
Hom.:
2
Cov.:
32
AF XY:
0.00111
AC XY:
83
AN XY:
74448
show subpopulations
Gnomad4 AFR
AF:
0.00363
Gnomad4 AMR
AF:
0.00150
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000103
Gnomad4 OTH
AF:
0.00189
Alfa
AF:
0.000214
Hom.:
0
Bravo
AF:
0.00117
ESP6500AA
AF:
0.00386
AC:
17
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000486
AC:
59
Asia WGS
AF:
0.000578
AC:
2
AN:
3476
EpiCase
AF:
0.000218
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:6Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:4Benign:1
Uncertain significance, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenMay 01, 2016- -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxAug 11, 2022In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Uncertain significance, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 17, 2017The p.Pro548His variant (rs143918373) has not been reported in the medical literature, gene specific variation databases, nor has it been previously identified by our laboratory. This variant is listed in the Genome Aggregation Database (gnomAD) with a frequency of 0.4 percent in the African population (identified on 95 out of 24,022 chromosomes) and has been reported to the ClinVar database (Variation ID: 178465). The proline at position 548 is highly conserved up to frog considering 11 species (Alamut v2.10) and computational analyses of the effects of the p.Pro548His variant on protein structure and function provide conflicting results (SIFT: tolerated, MutationTaster: disease causing, PolyPhen-2: benign). Altogether, there is not enough evidence to classify the p.Pro548His variant with certainty. -
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 02, 2024- -
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Feb 04, 2018- -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 04, 2023The c.1643C>A (p.P548H) alteration is located in exon 16 (coding exon 14) of the MYO3A gene. This alteration results from a C to A substitution at nucleotide position 1643, causing the proline (P) at amino acid position 548 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Autosomal recessive nonsyndromic hearing loss 30 Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineApr 30, 2012Pro548His in Exon 16 of MYO3A: This variant is not expected to have clinical sig nificance because it has been identified in 0.4% (15/3732) of African American c hromosomes from a broad population by the NHLBI Exome Sequencing Project (http:/ /evs.gs.washington.edu/EVS; dbSNP rs143918373). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.29
CADD
Uncertain
24
DANN
Benign
0.96
DEOGEN2
Uncertain
0.50
D;D;D
Eigen
Uncertain
0.28
Eigen_PC
Uncertain
0.27
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.90
.;D;D
M_CAP
Benign
0.048
D
MetaRNN
Benign
0.013
T;T;T
MetaSVM
Uncertain
0.16
D
MutationAssessor
Benign
1.6
L;L;.
MutationTaster
Benign
0.99
D;D
PrimateAI
Benign
0.46
T
PROVEAN
Uncertain
-3.4
.;D;D
REVEL
Uncertain
0.41
Sift
Benign
0.060
.;T;D
Sift4G
Benign
0.17
.;T;T
Polyphen
0.29
B;B;D
Vest4
0.49, 0.46
MVP
0.83
MPC
0.076
ClinPred
0.035
T
GERP RS
3.3
Varity_R
0.35
gMVP
0.36

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs143918373; hg19: chr10-26385390; API